Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the Children's Cancer Group

James Nachman, Harland N. Sather, Paul S. Gaynon, John N. Lukens, Lawrence Wolff, Michael E. Trigg

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the Children's Cancer Group'. Together they form a unique fingerprint.

Medicine & Life Sciences